Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

cyc 202 has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 1 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)		Trials
(n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)		Recent Studies (post-2010) (n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)
97973931491363

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide (IC50)
Tyrosine-protein kinase ABL1Homo sapiens (human)0.007
Carbonic anhydrase 1Homo sapiens (human)0.031
Carbonic anhydrase 2Homo sapiens (human)0.011
Dihydrofolate reductaseEscherichia coli K-120.007
Cyclin-dependent kinase 2Homo sapiens (human)0.007
Carbonic anhydrase 4Bos taurus (cattle)0.065

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blagden, S; de Bono, J1

Reviews

1 review(s) available for cyc 202 and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

ArticleYear
Drugging cell cycle kinases in cancer therapy.
    Current drug targets, 2005, Volume: 6, Issue:3

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Cyclin-Dependent Kinases; Flavonoids; Humans; Neoplasms; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Staurosporine; Sulfonamides; Thiazoles

2005